Gulesi Ayanoglu
Impact in
- Immunology top 5%
- T-cell and B-cell Immunology
- Psoriasis: Treatment and Pathogenesis
- IL-33, ST2, and ILC Pathways
- Oncology top 10%
- Cancer Immunotherapy and Biomarkers
- Cytokine Signaling Pathways and Interactions
Papers in
-
- T-cell and B-cell Immunology 2
- Immunotherapy and Immune Responses 2
- Psoriasis: Treatment and Pathogenesis 2
-
- Renal Diseases and Glomerulopathies 2
- Chronic Kidney Disease and Diabetes 2
- Co-authors
- Michael Judo (4 shared papers)Terrill K. McClanahan (4 shared papers)Yi Chen (3 shared papers)Muhammet Fatih Gulen (2 shared papers)Corinne Cayatte (2 shared papers)Xiaoxia Li (2 shared papers)Wendy M. Blumenschein (2 shared papers)Barbara Joyce-Shaikh (2 shared papers)
- Journals
- Immunity (2 papers)European Respiratory Journal (1 paper)Molecular Cancer Therapeutics (1 paper)Rapid Communications in Mass Spectrometry (1 paper)Bioanalysis (1 paper)
- Partner nations
- United StatesDenmarkChina
In The Last Decade
Gulesi Ayanoglu
17 papers receiving 1.4k citations
Gulesi Ayanoglu's Hit Papers
Peers
Comparison fields: 5 of 81
- Immunology 536
- Oncology 266
- Pharmacology 71
- Rheumatology 92
- Nephrology 62
Countries citing papers authored by Gulesi Ayanoglu
This map shows the geographic impact of Gulesi Ayanoglu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gulesi Ayanoglu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gulesi Ayanoglu more than expected).
Fields of papers citing papers by Gulesi Ayanoglu
This network shows the impact of papers produced by Gulesi Ayanoglu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gulesi Ayanoglu. The network helps show where Gulesi Ayanoglu may publish in the future.
Co-authors
The 25 scholars most cited alongside Gulesi Ayanoglu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Interleukin-23-Independent IL-17 Production Regulates Intestinal Epithelial Permeability Hit paper breakdown → | 2015 | 652 |
| 2 | 2011 | 357 | |
| 3 | 2013 | 124 | |
| 4 | 2015 | 119 | |
| 5 | 2016 | 62 | |
| 6 | 2015 | 48 | |
| 7 | 2015 | 22 | |
| 8 | 2020 | 17 | |
| 9 | 2010 | 14 | |
| 10 | 2013 | 14 | |
| 11 | 2020 | 13 | |
| 12 | 2010 | 9 | |
| 13 | 1979 | 6 | |
| 14 | Bioavailability and pharmacodynamics of a sustained-release glibenclamide product (Deroctyl) in comparison to a standard tablet formulation (Euglucon, Daonil). | 1983 | 5 |
| 15 | 2018 | 4 | |
| 16 | 2015 | 3 | |
| 17 | 2016 | 1 |
About Gulesi Ayanoglu
Gulesi Ayanoglu is a scholar working on Immunology, Nephrology, Spectroscopy, Molecular Biology and Oncology, having authored 17 papers that have together received 1.5k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (2 papers), Renal Diseases and Glomerulopathies (2 papers), Chronic Kidney Disease and Diabetes (2 papers), T-cell and B-cell Immunology (2 papers), Asthma and respiratory diseases (2 papers), Advanced Biosensing Techniques and Applications (2 papers), Immunotherapy and Immune Responses (2 papers) and Psoriasis: Treatment and Pathogenesis (2 papers). The work is most often cited by research in Immunology (536 citations), Oncology (266 citations), Pharmacology (71 citations), Rheumatology (92 citations) and Nephrology (62 citations). Gulesi Ayanoglu has collaborated with scholars based in United States, Denmark and China. Frequent co-authors include Michael Judo, Terrill K. McClanahan, Yi Chen, Muhammet Fatih Gulen, Corinne Cayatte, Xiaoxia Li, Wendy M. Blumenschein, Barbara Joyce-Shaikh, Cristina M. Tato and Jacob S. Lee. Their work appears in journals such as Immunity, European Respiratory Journal, Molecular Cancer Therapeutics, Rapid Communications in Mass Spectrometry and Bioanalysis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.